EUVIMEDEUVIMED entdecken
Editorial

Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022

Jennifer Jacobs, Jamie Lebhar, Carrie Diamond, Chandler Rundle, Christopher Stamey

Journal of Drugs in Dermatology · 01.03.2023 · 22 (3) · 310-311

DOI: 10.36849/jdd.7087 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.02.2023. Verfasst von Jennifer Jacobs und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Seborrheic, Keloid. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, SeborrheicKeloidHumansClinical Trials as TopicRacial GroupsBlack or African American

Zitieren

APA

Jacobs, J., Lebhar, J., Diamond, C., Rundle, C., & Stamey, C. (2023). Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022. Journal of Drugs in Dermatology, 22(3), 310-311. https://doi.org/10.36849/jdd.7087

Vancouver

Jacobs J, Lebhar J, Diamond C, Rundle C, Stamey C. Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022. Journal of Drugs in Dermatology. 2023;22(3):310-311. doi:10.36849/jdd.7087

BibTeX
@article{Jacobs2023,
  author = {Jacobs, Jennifer and Lebhar, Jamie and Diamond, Carrie and Rundle, Chandler and Stamey, Christopher},
  title = {Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022},
  journal = {Journal of Drugs in Dermatology},
  year = {2023},
  volume = {22},
  number = {3},
  pages = {310--311},
  doi = {10.36849/jdd.7087}
}
Kostenlos starten →